Europe Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type, By Application, By End Use, By Country and Growth Forecast, 2023

List of Tables

The Europe Specialty Generics Market would witness market growth of 9.3% CAGR during the forecast period (2023-2030).

The market share is anticipated to increase due to factors like the increasing incidence of diseases and the rising number of patent expirations. Chronic diseases, like cardiovascular conditions, cancer, and arthritis, among others, have become more prevalent recently, placing a considerable load on people's healthcare spending. A major factor driving the market is the rising prevalence of complex chronic diseases like hepatitis C and the growing use of specialty generic medications.

The generic version of that drug is referred to as its "specialty generic," and the word "specialty generics" is the term used to describe those generic versions. Multiple sclerosis, cancer, and rheumatoid arthritis are examples of diseases that can be effectively treated with these pharmaceuticals. When compared to their branded counterparts, specialty generics are significantly less expensive due to the lower expenses associated with their development and marketing.

Since younger birth cohorts also exhibit declining populations, according to Destatis, 2020, adults over 65 also make up an increasing share of the overall population over time. From 15% in 1991 to 22% in 2019, it increased. The number of people who are very old and over 85 is growing especially quickly. In 1991, there were 1.2 million of them, and by 2019, there were 2.4 million. According to a UN assessment of France aging policy, France, like other European nations, is experiencing a steady and large rise in the population of senior people. In 2012, there were 15 million persons in France over the age of 60. In 2060, this number will increase to 24 million. It is anticipated that the market will grow as a result of the aging populations in these regional nations.

The Germany market dominated the Europe Specialty Generics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $8,947.8 million by 2030. The UK market is experiencing a CAGR of 8.4% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 10.1% during (2023 - 2030).

Based on Type, the market is segmented into Injectables, Oral Drugs, and Others. Based on Application, the market is segmented into Inflammatory conditions, Multiple sclerosis, Hepatitis C, Oncology, and Others. Based on End Use, the market is segmented into Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Novartis AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Ltd., Mallinckrodt PLC, Bausch Health Companies, Inc., Viatris, Inc. and Apotex, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

Injectables
Oral Drugs
Others

By Application

Inflammatory conditions
Multiple sclerosis
Hepatitis C
Oncology
Others

By End Use

Specialty Pharmacy
Retail Pharmacy
Hospital Pharmacy

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

Teva Pharmaceuticals Industries Ltd.
Novartis AG
Hikma Pharmaceuticals PLC
Sun Pharmaceutical Industries Ltd.
Fresenius SE & Co. KGaA
Dr. Reddy's Laboratories Ltd.
Mallinckrodt PLC
Bausch Health Companies, Inc.
Viatris, Inc.
Apotex, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Specialty Generics Market, by Type
- 1.4.2 Europe Specialty Generics Market, by Application
- 1.4.3 Europe Specialty Generics Market, by End Use
- 1.4.4 Europe Specialty Generics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, May - 2023, Jan) Leading Players

Chapter 4. Europe Specialty Generics Market by Type

4.1 Europe Injectables Market by Country
4.2 Europe Oral Drugs Market by Country
4.3 Europe Others Market by Country

Chapter 5. Europe Specialty Generics Market by Application

5.1 Europe Inflammatory conditions Market by Country
5.2 Europe Multiple sclerosis Market by Country
5.3 Europe Hepatitis C Market by Country
5.4 Europe Oncology Market by Country
5.5 Europe Others Market by Country

Chapter 6. Europe Specialty Generics Market by End Use

6.1 Europe Specialty Pharmacy Market by Country
6.2 Europe Retail Pharmacy Market by Country
6.3 Europe Hospital Pharmacy Market by Country

Chapter 7. Europe Specialty Generics Market by Country

7.1 Germany Specialty Generics Market
- 7.1.1 Germany Specialty Generics Market by Type
- 7.1.2 Germany Specialty Generics Market by Application
- 7.1.3 Germany Specialty Generics Market by End Use
7.2 UK Specialty Generics Market
- 7.2.1 UK Specialty Generics Market by Type
- 7.2.2 UK Specialty Generics Market by Application
- 7.2.3 UK Specialty Generics Market by End Use
7.3 France Specialty Generics Market
- 7.3.1 France Specialty Generics Market by Type
- 7.3.2 France Specialty Generics Market by Application
- 7.3.3 France Specialty Generics Market by End Use
7.4 Russia Specialty Generics Market
- 7.4.1 Russia Specialty Generics Market by Type
- 7.4.2 Russia Specialty Generics Market by Application
- 7.4.3 Russia Specialty Generics Market by End Use
7.5 Spain Specialty Generics Market
- 7.5.1 Spain Specialty Generics Market by Type
- 7.5.2 Spain Specialty Generics Market by Application
- 7.5.3 Spain Specialty Generics Market by End Use
7.6 Italy Specialty Generics Market
- 7.6.1 Italy Specialty Generics Market by Type
- 7.6.2 Italy Specialty Generics Market by Application
- 7.6.3 Italy Specialty Generics Market by End Use
7.7 Rest of Europe Specialty Generics Market
- 7.7.1 Rest of Europe Specialty Generics Market by Type
- 7.7.2 Rest of Europe Specialty Generics Market by Application
- 7.7.3 Rest of Europe Specialty Generics Market by End Use

Chapter 8. Company Profiles

8.1 Teva Pharmaceutical Industries Ltd.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 Recent strategies and developments:
  - 8.1.5.1 Partnerships, Collaborations, and Agreements:
  - 8.1.5.2 Product Launches and Product Expansions:
8.2 Novartis AG
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Partnerships, Collaborations, and Agreements:
  - 8.2.5.2 Acquisition and Mergers:
8.3 Hikma Pharmaceuticals PLC
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Partnerships, Collaborations, and Agreements:
  - 8.3.5.2 Product Launches and Product Expansions:
8.4 Sun Pharmaceutical Industries Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Partnerships, Collaborations, and Agreements:
  - 8.4.5.2 Product Launches and Product Expansions:
8.5 Fresenius SE & Co. KGaA
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Acquisition and Mergers:
8.6 Dr. Reddy's Laboratories Ltd.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 Recent strategies and developments:
  - 8.6.5.1 Product Launches and Product Expansions:
8.7 Mallinckrodt PLC
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 Recent strategies and developments:
  - 8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 Recent strategies and developments:
  - 8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Viatris, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 Recent strategies and developments:
  - 8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Apotex, Inc.
- 8.10.1 Company Overview

LIST OF TABLES

TABLE 1 Europe Specialty Generics Market, 2019 - 2022, USD Million
TABLE 2 Europe Specialty Generics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Specialty Generics Market
TABLE 4 Product Launches And Product Expansions- Specialty Generics Market
TABLE 5 Acquisition and Mergers- Specialty Generics Market
TABLE 6 Approvals and Trials- Specialty Generics Market
TABLE 7 Europe Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 8 Europe Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 9 Europe Injectables Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Injectables Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Oral Drugs Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Oral Drugs Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 16 Europe Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 17 Europe Inflammatory conditions Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Inflammatory conditions Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Multiple sclerosis Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Multiple sclerosis Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Hepatitis C Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Hepatitis C Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Oncology Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Oncology Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 28 Europe Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 29 Europe Specialty Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Specialty Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Specialty Generics Market by Country, 2019 - 2022, USD Million
TABLE 36 Europe Specialty Generics Market by Country, 2023 - 2030, USD Million
TABLE 37 Germany Specialty Generics Market, 2019 - 2022, USD Million
TABLE 38 Germany Specialty Generics Market, 2023 - 2030, USD Million
TABLE 39 Germany Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 40 Germany Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 41 Germany Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 42 Germany Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 43 Germany Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 44 Germany Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 45 UK Specialty Generics Market, 2019 - 2022, USD Million
TABLE 46 UK Specialty Generics Market, 2023 - 2030, USD Million
TABLE 47 UK Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 48 UK Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 49 UK Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 50 UK Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 51 UK Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 52 UK Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 53 France Specialty Generics Market, 2019 - 2022, USD Million
TABLE 54 France Specialty Generics Market, 2023 - 2030, USD Million
TABLE 55 France Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 56 France Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 57 France Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 58 France Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 59 France Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 60 France Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 61 Russia Specialty Generics Market, 2019 - 2022, USD Million
TABLE 62 Russia Specialty Generics Market, 2023 - 2030, USD Million
TABLE 63 Russia Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 64 Russia Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 65 Russia Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 66 Russia Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 67 Russia Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 68 Russia Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 69 Spain Specialty Generics Market, 2019 - 2022, USD Million
TABLE 70 Spain Specialty Generics Market, 2023 - 2030, USD Million
TABLE 71 Spain Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 72 Spain Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 73 Spain Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 74 Spain Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 75 Spain Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 76 Spain Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 77 Italy Specialty Generics Market, 2019 - 2022, USD Million
TABLE 78 Italy Specialty Generics Market, 2023 - 2030, USD Million
TABLE 79 Italy Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 80 Italy Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 81 Italy Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 82 Italy Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 83 Italy Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 84 Italy Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 85 Rest of Europe Specialty Generics Market, 2019 - 2022, USD Million
TABLE 86 Rest of Europe Specialty Generics Market, 2023 - 2030, USD Million
TABLE 87 Rest of Europe Specialty Generics Market by Type, 2019 - 2022, USD Million
TABLE 88 Rest of Europe Specialty Generics Market by Type, 2023 - 2030, USD Million
TABLE 89 Rest of Europe Specialty Generics Market by Application, 2019 - 2022, USD Million
TABLE 90 Rest of Europe Specialty Generics Market by Application, 2023 - 2030, USD Million
TABLE 91 Rest of Europe Specialty Generics Market by End Use, 2019 - 2022, USD Million
TABLE 92 Rest of Europe Specialty Generics Market by End Use, 2023 - 2030, USD Million
TABLE 93 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 94 Key Information - Novartis AG
TABLE 95 Key Information - Hikma Pharmaceuticals PLC
TABLE 96 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 97 key information - Fresenius SE & Co. KGaA
TABLE 98 key information - Dr. Reddy's Laboratories Ltd.
TABLE 99 Key information - Mallinckrodt PLC
TABLE 100 key information - Bausch Health Companies, Inc.
TABLE 101 key information - Viatris, Inc.
TABLE 102 Key Information - Apotex, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2020, May - 2023, Jan) Leading Players
FIG 5 Europe Specialty Generics Market share by Type, 2022
FIG 6 Europe Specialty Generics Market share by Type, 2030
FIG 7 Europe Specialty Generics Market by Type, 2019 - 2030, USD Million
FIG 8 Europe Specialty Generics Market share by Application, 2022
FIG 9 Europe Specialty Generics Market share by Application, 2030
FIG 10 Europe Specialty Generics Market by Application, 2019 - 2030, USD Million
FIG 11 Europe Specialty Generics Market share by End Use, 2022
FIG 12 Europe Specialty Generics Market share by End Use, 2030
FIG 13 Europe Specialty Generics Market by End Use, 2019 - 2030, USD Million
FIG 14 Europe Specialty Generics Market share by Country, 2022
FIG 15 Europe Specialty Generics Market share by Country, 2030
FIG 16 Europe Specialty Generics Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 18 Recent strategies and developments: Novartis AG
FIG 19 Recent strategies and developments: Hikma Pharmaceuticals PLC
FIG 20 Recent strategies and developments: Sun Pharmaceutical Industries Ltd.

Europe Specialty Generics Market Size, Share & Industry Trends Analysis Report By Type, By Application, By End Use, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents